RecoveryIntermediate

Ultimate Recovery Stack

The most researched peptide combination for accelerating tissue repair, reducing inflammation, and returning to peak performance after injury or intense training.

RecoveryInjury RepairAnti-inflammatoryTendonMuscle

Protocol Summary

Duration

8–12 weeks

Difficulty

Intermediate

Peptides

2 compounds

Audience

Biohackers, Athletes

Personalize This Stack

Why This Stack Works

BPC-157 and TB-500 are widely regarded as the gold standard recovery stack. Together they address healing from multiple angles — BPC-157 targets local tissue repair and gut health while TB-500 provides systemic, body-wide healing via actin upregulation. The combination is synergistic: BPC-157 accelerates the initial repair cascade while TB-500 promotes long-term tissue remodeling and flexibility.

Peptide Breakdown

BPC-157

250 mcg

Frequency

Twice daily

Route

Subcutaneous injection

Inject near the site of injury for best results

TB-500

2 mg

Frequency

Twice weekly (loading), then 2 mg every 2 weeks (maintenance)

Route

Subcutaneous injection

Systemic distribution — injection site is less critical

Protocol Schedule

Weeks 1–4 (Loading): BPC-157 250 mcg twice daily + TB-500 2 mg twice weekly. Weeks 5–12 (Maintenance): Continue BPC-157 twice daily, reduce TB-500 to 2 mg every 2 weeks. Take a 4-week break after the full cycle.

Expected Results

Significant reduction in pain and inflammation within 1–2 weeks. Accelerated healing of tendons, ligaments, and muscle tissue. Improved range of motion and flexibility. Most users report 30–50% faster recovery from acute injuries.

Research Notes

Both peptides have extensive animal study data supporting their synergistic use. BPC-157 has been studied in over 100 published papers. TB-500 (Thymosin Beta-4) has clinical trial data in cardiac repair.

Sikiric et al. (2016) — BPC-157 in inflammatory bowel disease and systemic healing

Current Pharmaceutical Design

Philp et al. (2004) — Thymosin beta4 accelerates wound healing

Annals of the New York Academy of Sciences

Cautions & Contraindications

Both peptides have angiogenic properties — avoid with active malignancy. Consult a physician before use. Not for use during pregnancy.

Educational use only. This protocol is for informational purposes and does not constitute medical advice. Consult a qualified healthcare provider before beginning any peptide protocol.